Zymergi LogoCart

EIR Document: Boehringer Ingelheim Fremont, Inc., Nov 4, 2022

FDANews EIR Boehringer Ingelheim Fremont, Inc. Nov 4 2022 top
Jeffrey P. Raimondi FDA Investigator Christopher R. Czajka FDA Investigator

Establishment Inspection Report for the FDA inspection at Boehringer Ingelheim Fremont, Inc.'s Fremont site on Nov 04, 2022. Get detailed insights.